BSPP (drug)

BSPP (N-benzyl-2-(2,3-dihydro-1,4-benzodioxin-2-ylmethylsulfanyl)-3,5-difluorobenzamide) is a chemical compound that acts as a positive allosteric modulator of the GABAB receptor. It is used primarily in scientific research to study the function and pharmacology of the GABAB receptor.
Chemical Structure and Properties[edit]
BSPP is characterized by its unique chemical structure, which includes a benzodioxin ring, a benzyl group, and a difluorobenzamide moiety. The presence of these groups contributes to its activity as a modulator of the GABAB receptor.
Mechanism of Action[edit]
As a positive allosteric modulator, BSPP binds to a site on the GABAB receptor that is distinct from the binding site of the endogenous ligand, gamma-Aminobutyric acid (GABA). By binding to this allosteric site, BSPP enhances the receptor's response to GABA, leading to increased inhibitory neurotransmission.
Research Applications[edit]
BSPP is used in neuroscience research to investigate the role of GABAB receptors in various physiological and pathological processes. It has been employed in studies examining synaptic plasticity, pain modulation, and neuroprotection. Additionally, BSPP has been used to explore the potential therapeutic benefits of GABAB receptor modulation in conditions such as epilepsy, anxiety, and depression.
Pharmacokinetics[edit]
The pharmacokinetic properties of BSPP, including its absorption, distribution, metabolism, and excretion, are important for understanding its effects in vivo. Studies have shown that BSPP can cross the blood-brain barrier, allowing it to exert its effects on central nervous system GABAB receptors.
Safety and Toxicology[edit]
As with any research chemical, the safety and toxicology profile of BSPP must be carefully considered. While it is generally used in controlled laboratory settings, information on its long-term effects and potential toxicity in humans is limited.
See Also[edit]
- GABAB receptor
- Allosteric modulator
- Neurotransmission
- Synaptic plasticity
- Epilepsy
- Anxiety
- Depression
References[edit]
External Links[edit]
-
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
